Detailed instructions for cabergoline and a comprehensive medication guide!

Cabergoline trade nameDostinex is a dopamine receptor agonist mainly used to treat hyperprolactinemia (HPRL) caused by pituitary adenoma or other causes. Prolactin is a hormone secreted by the anterior pituitary gland. Excessive prolactin can lead to symptoms such as irregular menstruation, galactorrhea, and loss of sexual desire. The mechanism of action of cabergoline is to activate dopamine receptors, inhibit the secretion of prolactin, and thereby relieve related symptoms. As the drug of choice for the treatment of hyperprolactinemia, cabergoline is widely used due to its high efficacy and good tolerability.

1. Indications

Cabergoline is indicated for the treatment of idiopathic or pituitary adenomatous hyperprolactinemia. In such patients, pituitary adenomas (usually benign tumors) overproduce prolactin, leading to symptoms such as irregular menstruation, anovulation, and infertility in women, and decreased libido and erectile dysfunction in men. For these patients, cabergoline can effectively reduce prolactin secretion and relieve symptoms. It should be noted that cabergoline is not suitable for inhibiting physiological lactation, such as postpartum lactation.

2. Usage and dosage

The method and dosage of cabergoline will be adjusted according to the patient's specific condition. Usually, the starting dose of treatment is 0.25 mg twice a week. When patients initially take the drug, the effect of the drug may be slow, so the dose needs to be individually adjusted based on serum prolactin levels. It is recommended that the interval between each dose adjustment is at least 4 weeks, with each increase of 0.25 mg, twice a week. Based on the patient's efficacy and tolerability, the maximum dose can be adjusted to 1 mg twice a week.

Once the patient's serum prolactin level returns to the normal range and is stable for 6 months, the physician may consider discontinuing the drug. After stopping the drug, patients need to regularly monitor serum prolactin levels. If prolactin levels increase or symptoms relapse, treatment may need to be restarted.

3. Precautions and efficacy

The therapeutic effect of cabergoline is usually good, and most patients will see a decrease in prolactin levels and relief of symptoms within a few weeks of taking the drug. However, the efficacy of cabergoline varies among individuals, and there are no clear conclusions on the long-term effects of using the drug for more than 24 months. Therefore, for patients on long-term medication, regular medical evaluation and blood testing is very important to ensure the continued effectiveness and safety of treatment.

Cabergoline is generally a safe and effective treatment option for patients, but some adverse reactions may occur, such as dizziness, gastrointestinal discomfort, hypotension, etc. Some patients may develop heart valve abnormalities, so heart health needs to be monitored regularly during treatment.

In summary, cabergoline is an important drug in the treatment of hyperprolactinemia, and its treatment regimen should be personalized based on the patient's specific conditions. Patients should use drugs under the guidance of professional doctors to ensure the safety and effectiveness of treatment.

Reference materials:https://my.clevelandclinic.org/health/drugs/20863-cabergoline-tablets